Article
Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC
2026-08-20
Abstract excerpt
<title>Abstract</title> <p> <underline>Background</underline> Non-small cell lung cancer (NSCLC) is characterized by a high recurrence rate after curative resection of early-stage disease and a poor overall survival. Although targeted therapy and immunotherapy have reshaped the standard-of-care (SOC) of NSCLC, chemotherapy, particularly platinum-doublet regimens, remains a key treatment modality in early-stage,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 59a13f95-34b8-5c6b-b637-d4f36c806b46
- DOI
- 10.21203/rs.3.rs-10535379/v1
